Jennifer Zhou, Ph.D.
Patent Agent
Jennifer Zhou, Ph.D.
Patent Agent
Dr. Jennifer Zhou is a patent agent in the Irvine office of Maschoff Brennan, where she focuses on intellectual property (IP) law. Her practice has a strong life science focus, and includes patent application drafting and prosecution, freedom to operate analyses, non-infringement and invalidity opinion in the chemistry art.
Prior to joining the firm, Dr. Zhou worked as a Patent Agent at K&L Gates practicing patent law in life science and technology. Dr. Zhou has more than 10 years of medicinal chemistry experience at a number of biotech and pharmaceutical companies, in drug discovery research on several biological targets.
She has various management roles such as Director of Chemistry Department, Project Leader of a 30+ member interdisciplinary drug discovery research team, and was a lead medicinal chemist on four drug discovery programs which resulted in clinical development candidates. She has extensive experience in structure-based ligand design for drug discovery research. Dr. Zhou has published 42 peer reviewed papers in scientific journals, and speaks fluent Chinese.
-
Education
- Postdoctoral Fellow, Chemistry, Texas A&M University
- Ph.D., Organic Chemistry, Shanghai Institute of Organic Chemistry (SIOC)
- B.S., Chemistry, Suzhou (Soochow) University, Suzhou, China
-
Technical Experience
- Pharmaceuticals
- Medicinal Chemistry
- Organic Chemistry
- Organometallic Chemistry
- Polymer Chemistry
- Surface Chemistry
- Combinatorial chemistry
- Drug discovery research
-
Professional Admissions & Associations
- United States Patent & Trademark Office
-
Publications, Speaking Engagements & Presentations
- “Strategic and Practical Considerations for Accelerated Examination in the United States,” Patent Lawyer Magazine (March/April 2022)
- “Today’s Investment, Tomorrow’s Return,” Orange County Business Journal (May 2020)
-
Second Language
- Chinese
-
Awards & Recognition
Patexia Insights – Ranked #1, Best Performing Attorney in Biotech and Ranked #52, Most Active Attorney in Biotech
News and Articles